| 0 |
VASCULAR ANASTOMOTIC HAEMORRHAGE |
19 |
0.6333 |
| 1 |
APPLICATION SITE PLAQUE |
6 |
0.2609 |
| 2 |
APPLICATION SITE DRYNESS |
746 |
0.2195 |
| 3 |
APPLICATION SITE ACNE |
106 |
0.2163 |
| 4 |
DANDRUFF |
475 |
0.2145 |
| 5 |
PERINEAL CYST |
14 |
0.1918 |
| 6 |
APPLICATION SITE ULCER |
134 |
0.1893 |
| 7 |
VENA CAVA INJURY |
17 |
0.1848 |
| 8 |
HYPERTRICHOSIS |
286 |
0.1542 |
| 9 |
APPLICATION SITE PAPULES |
160 |
0.1508 |
| 10 |
PANCREATIC CYSTADENOMA |
7 |
0.1458 |
| 11 |
INJECTION SITE ALOPECIA |
6 |
0.1364 |
| 12 |
APPLICATION SITE EXFOLIATION |
544 |
0.1319 |
| 13 |
APPLICATION SITE PRURITUS |
2580 |
0.1136 |
| 14 |
RENAL CYST HAEMORRHAGE |
24 |
0.1062 |
| 15 |
ANAL CYST |
6 |
0.1034 |
| 16 |
APPLICATION SITE IRRITATION |
1250 |
0.1004 |
| 17 |
APPLICATION SITE SCAB |
212 |
0.0981 |
| 18 |
APPLICATION SITE FOLLICULITIS |
7 |
0.0972 |
| 19 |
ADVERSE DRUG REACTION |
8609 |
0.0958 |
| 20 |
HAIR INJURY |
26 |
0.0875 |
| 21 |
APPLICATION SITE ECZEMA |
6 |
0.0690 |
| 22 |
APPLICATION SITE FISSURE |
6 |
0.0667 |
| 23 |
LICHEN PLANOPILARIS |
7 |
0.0593 |
| 24 |
VASCULAR COMPRESSION |
18 |
0.0570 |
| 25 |
GENITAL DISORDER |
7 |
0.0522 |
| 26 |
APPLICATION SITE PAIN |
1109 |
0.0503 |
| 27 |
ABDOMINAL WALL HAEMORRHAGE |
13 |
0.0498 |
| 28 |
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM |
15 |
0.0495 |
| 29 |
APPLICATION SITE WOUND |
8 |
0.0485 |
| 30 |
APPLICATION SITE INJURY |
9 |
0.0474 |
| 31 |
CENTRAL SEROUS CHORIORETINOPATHY |
32 |
0.0469 |
| 32 |
APPLICATION SITE PARAESTHESIA |
60 |
0.0460 |
| 33 |
APPLICATION SITE INFLAMMATION |
59 |
0.0426 |
| 34 |
APPLICATION SITE PUSTULES |
15 |
0.0411 |
| 35 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
674 |
0.0367 |
| 36 |
APPLICATION SITE NODULE |
5 |
0.0365 |
| 37 |
APPLICATION SITE DISCOMFORT |
64 |
0.0356 |
| 38 |
POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME |
10 |
0.0352 |
| 39 |
MIXED ANXIETY AND DEPRESSIVE DISORDER |
13 |
0.0351 |
| 40 |
BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED |
10 |
0.0345 |
| 41 |
APPLICATION SITE HYPOAESTHESIA |
8 |
0.0342 |
| 42 |
GLOMERULONEPHRITIS ACUTE |
7 |
0.0340 |
| 43 |
APPLICATION SITE INFECTION |
17 |
0.0334 |
| 44 |
APPLICATION SITE DISCHARGE |
37 |
0.0321 |
| 45 |
APPLICATION SITE RASH |
434 |
0.0315 |
| 46 |
DELAYED GRAFT FUNCTION |
22 |
0.0309 |
| 47 |
HAIR TEXTURE ABNORMAL |
385 |
0.0288 |
| 48 |
HYPERPARATHYROIDISM SECONDARY |
71 |
0.0283 |
| 49 |
ANDROGENETIC ALOPECIA |
8 |
0.0282 |
| 50 |
SKIN FIBROSIS |
13 |
0.0269 |
| 51 |
PAINFUL EJACULATION |
6 |
0.0265 |
| 52 |
EXPOSURE VIA EYE CONTACT |
11 |
0.0261 |
| 53 |
MYOCARDIAL NECROSIS |
6 |
0.0258 |
| 54 |
ALOPECIA UNIVERSALIS |
7 |
0.0239 |
| 55 |
INTERVERTEBRAL DISC SPACE NARROWING |
19 |
0.0236 |
| 56 |
APPLICATION SITE HYPERSENSITIVITY |
28 |
0.0230 |
| 57 |
APPLICATION SITE ERYTHEMA |
603 |
0.0230 |
| 58 |
PENILE SIZE REDUCED |
21 |
0.0221 |
| 59 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
23 |
0.0217 |
| 60 |
CAROTID ARTERIOSCLEROSIS |
22 |
0.0213 |
| 61 |
TRICHORRHEXIS |
59 |
0.0211 |
| 62 |
HAIR COLOUR CHANGES |
262 |
0.0210 |
| 63 |
AORTIC DILATATION |
23 |
0.0207 |
| 64 |
PNEUMONIA HAEMOPHILUS |
10 |
0.0206 |
| 65 |
NEPHROGENIC ANAEMIA |
92 |
0.0198 |
| 66 |
APPLICATION SITE HAEMORRHAGE |
54 |
0.0198 |
| 67 |
APPLICATION SITE BURN |
93 |
0.0189 |
| 68 |
SCROTAL OEDEMA |
13 |
0.0183 |
| 69 |
TESTICULAR PAIN |
58 |
0.0183 |
| 70 |
SEBORRHOEA |
67 |
0.0182 |
| 71 |
RECTAL PROLAPSE |
22 |
0.0182 |
| 72 |
HAIR GROWTH ABNORMAL |
126 |
0.0182 |
| 73 |
RENAL ARTERY STENOSIS |
25 |
0.0181 |
| 74 |
APPLICATION SITE VESICLES |
116 |
0.0179 |
| 75 |
PRODUCT LABEL ON WRONG PRODUCT |
7 |
0.0177 |
| 76 |
PLEUROPERICARDITIS |
7 |
0.0170 |
| 77 |
MUSCULAR DYSTROPHY |
7 |
0.0161 |
| 78 |
TESTICULAR ATROPHY |
14 |
0.0161 |
| 79 |
EAR SWELLING |
34 |
0.0160 |
| 80 |
PRODUCT MONITORING ERROR |
23 |
0.0159 |
| 81 |
APPLICATION SITE WARMTH |
20 |
0.0157 |
| 82 |
BLADDER TRANSITIONAL CELL CARCINOMA |
22 |
0.0154 |
| 83 |
CHEMICAL BURN |
17 |
0.0147 |
| 84 |
LIBIDO DISORDER |
19 |
0.0146 |
| 85 |
ARTERIOVENOUS FISTULA |
7 |
0.0142 |
| 86 |
NEPHROGENIC SYSTEMIC FIBROSIS |
43 |
0.0142 |
| 87 |
SEMEN VOLUME DECREASED |
14 |
0.0140 |
| 88 |
APPLICATION SITE DERMATITIS |
13 |
0.0139 |
| 89 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
146 |
0.0138 |
| 90 |
MEIBOMIAN GLAND DYSFUNCTION |
6 |
0.0132 |
| 91 |
APPLICATION SITE REACTION |
83 |
0.0118 |
| 92 |
LAZINESS |
20 |
0.0117 |
| 93 |
SKIN WRINKLING |
31 |
0.0114 |
| 94 |
END STAGE RENAL DISEASE |
205 |
0.0112 |
| 95 |
JOINT CONTRACTURE |
12 |
0.0112 |
| 96 |
SEBORRHOEIC DERMATITIS |
18 |
0.0109 |
| 97 |
CARDIAC HYPERTROPHY |
12 |
0.0108 |
| 98 |
PRODUCT FORMULATION ISSUE |
70 |
0.0106 |
| 99 |
INTELLECTUAL DISABILITY |
16 |
0.0105 |
| 100 |
SKIN TEXTURE ABNORMAL |
10 |
0.0104 |
| 101 |
BLOOD OESTROGEN INCREASED |
6 |
0.0102 |
| 102 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
23 |
0.0101 |
| 103 |
INGROWN HAIR |
7 |
0.0101 |
| 104 |
HYPERTENSIVE ENCEPHALOPATHY |
6 |
0.0101 |
| 105 |
EXPIRED PRODUCT ADMINISTERED |
336 |
0.0101 |
| 106 |
ACTINIC KERATOSIS |
26 |
0.0100 |
| 107 |
PENIS DISORDER |
24 |
0.0097 |
| 108 |
LOSS OF LIBIDO |
87 |
0.0097 |
| 109 |
SKIN INDURATION |
20 |
0.0096 |
| 110 |
SEXUAL DYSFUNCTION |
113 |
0.0096 |
| 111 |
DARK CIRCLES UNDER EYES |
14 |
0.0095 |
| 112 |
EXTREMITY CONTRACTURE |
6 |
0.0094 |
| 113 |
LEFT VENTRICULAR HYPERTROPHY |
40 |
0.0093 |
| 114 |
VANISHING BILE DUCT SYNDROME |
10 |
0.0090 |
| 115 |
MEAN CELL VOLUME INCREASED |
23 |
0.0090 |
| 116 |
AORTIC ARTERIOSCLEROSIS |
23 |
0.0089 |
| 117 |
APPLICATION SITE DISCOLOURATION |
36 |
0.0089 |
| 118 |
GENITAL HYPOAESTHESIA |
9 |
0.0088 |
| 119 |
COLLAGEN DISORDER |
5 |
0.0087 |
| 120 |
SKIN SENSITISATION |
9 |
0.0087 |
| 121 |
HEPATOSPLENOMEGALY |
22 |
0.0086 |
| 122 |
HYPERTENSIVE EMERGENCY |
10 |
0.0085 |
| 123 |
ERECTILE DYSFUNCTION |
218 |
0.0085 |
| 124 |
AURICULAR SWELLING |
5 |
0.0083 |
| 125 |
MALIGNANT HYPERTENSION |
7 |
0.0081 |
| 126 |
RENAL TRANSPLANT FAILURE |
8 |
0.0081 |
| 127 |
APPLICATION SITE SWELLING |
39 |
0.0078 |
| 128 |
HYPERPARATHYROIDISM |
15 |
0.0073 |
| 129 |
APPLICATION SITE SCAR |
9 |
0.0072 |
| 130 |
SWELLING OF EYELID |
45 |
0.0072 |
| 131 |
DRUG ADMINISTERED IN WRONG DEVICE |
7 |
0.0072 |
| 132 |
CARDIAC TAMPONADE |
34 |
0.0071 |
| 133 |
CHORIORETINOPATHY |
10 |
0.0070 |
| 134 |
APPLICATION SITE EROSION |
9 |
0.0070 |
| 135 |
PERIORBITAL SWELLING |
38 |
0.0067 |
| 136 |
REBOUND ACID HYPERSECRETION |
20 |
0.0066 |
| 137 |
EJACULATION FAILURE |
13 |
0.0065 |
| 138 |
SKIN TEST POSITIVE |
6 |
0.0064 |
| 139 |
SKIN HYPERTROPHY |
18 |
0.0064 |
| 140 |
NIPPLE PAIN |
13 |
0.0064 |
| 141 |
ALOPECIA AREATA |
11 |
0.0063 |
| 142 |
PERICARDIAL EFFUSION |
142 |
0.0061 |
| 143 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
27 |
0.0059 |
| 144 |
AORTIC VALVE INCOMPETENCE |
25 |
0.0059 |
| 145 |
APPLICATION SITE URTICARIA |
13 |
0.0058 |
| 146 |
HYPERTENSIVE NEPHROPATHY |
6 |
0.0056 |
| 147 |
SPINAL STENOSIS |
23 |
0.0056 |
| 148 |
ALLERGIC REACTION TO EXCIPIENT |
11 |
0.0055 |
| 149 |
SKIN TIGHTNESS |
25 |
0.0053 |
| 150 |
OCULAR HYPERTENSION |
10 |
0.0051 |
| 151 |
DIVERTICULUM INTESTINAL |
22 |
0.0050 |
| 152 |
BENIGN PROSTATIC HYPERPLASIA |
25 |
0.0048 |
| 153 |
PERIORBITAL OEDEMA |
25 |
0.0048 |
| 154 |
DRUG INEFFECTIVE |
6284 |
0.0048 |
| 155 |
MENTAL FATIGUE |
7 |
0.0047 |
| 156 |
ALOPECIA |
907 |
0.0046 |
| 157 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
10 |
0.0045 |
| 158 |
HIRSUTISM |
6 |
0.0045 |
| 159 |
PAPULE |
31 |
0.0044 |
| 160 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
22 |
0.0043 |
| 161 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
781 |
0.0043 |
| 162 |
EPIDIDYMITIS |
5 |
0.0043 |
| 163 |
ALLODYNIA |
5 |
0.0043 |
| 164 |
EJACULATION DISORDER |
12 |
0.0042 |
| 165 |
FIBROSIS |
13 |
0.0042 |
| 166 |
CHRONIC KIDNEY DISEASE |
316 |
0.0042 |
| 167 |
RENAL TRANSPLANT |
15 |
0.0041 |
| 168 |
BICYTOPENIA |
8 |
0.0041 |
| 169 |
DISTRIBUTIVE SHOCK |
9 |
0.0040 |
| 170 |
KIDNEY TRANSPLANT REJECTION |
19 |
0.0040 |
| 171 |
LARGE INTESTINE POLYP |
27 |
0.0039 |
| 172 |
OLIGURIA |
24 |
0.0039 |
| 173 |
ESSENTIAL HYPERTENSION |
7 |
0.0038 |
| 174 |
SQUAMOUS CELL CARCINOMA OF SKIN |
23 |
0.0038 |
| 175 |
BLOOD PARATHYROID HORMONE INCREASED |
11 |
0.0038 |
| 176 |
ACROCHORDON |
5 |
0.0038 |
| 177 |
EAR PRURITUS |
13 |
0.0037 |
| 178 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
263 |
0.0037 |
| 179 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
16 |
0.0037 |
| 180 |
ELECTROCARDIOGRAM T WAVE INVERSION |
8 |
0.0036 |
| 181 |
RENAL CYST |
28 |
0.0035 |
| 182 |
RENAL FAILURE CHRONIC |
27 |
0.0035 |
| 183 |
HYPERTENSIVE CRISIS |
39 |
0.0035 |
| 184 |
METHAEMOGLOBINAEMIA |
8 |
0.0035 |
| 185 |
BRAIN FOG |
54 |
0.0034 |
| 186 |
BLOOD TESTOSTERONE DECREASED |
23 |
0.0034 |
| 187 |
DERMATITIS CONTACT |
38 |
0.0033 |
| 188 |
SCAB |
38 |
0.0033 |
| 189 |
HYPERSENSITIVITY |
613 |
0.0033 |
| 190 |
BLOOD PHOSPHORUS INCREASED |
9 |
0.0033 |
| 191 |
GLOMERULONEPHRITIS |
8 |
0.0033 |
| 192 |
DERMAL CYST |
8 |
0.0033 |
| 193 |
HYPERPHOSPHATAEMIA |
7 |
0.0033 |
| 194 |
AZOTAEMIA |
13 |
0.0033 |
| 195 |
DRUG EFFECT LESS THAN EXPECTED |
48 |
0.0032 |
| 196 |
VENTRICULAR HYPERTROPHY |
8 |
0.0032 |
| 197 |
ARTERIOSCLEROSIS |
30 |
0.0032 |
| 198 |
SPINAL OSTEOARTHRITIS |
28 |
0.0032 |
| 199 |
SWELLING FACE |
201 |
0.0031 |
| 200 |
ANGIONEUROTIC OEDEMA |
8 |
0.0030 |
| 201 |
BLOOD POTASSIUM INCREASED |
48 |
0.0030 |
| 202 |
SUSPECTED OFF LABEL USE |
13 |
0.0029 |
| 203 |
NAIL DISCOLOURATION |
11 |
0.0028 |
| 204 |
SKIN IRRITATION |
128 |
0.0028 |
| 205 |
PORTAL VEIN THROMBOSIS |
9 |
0.0028 |
| 206 |
UNDERDOSE |
200 |
0.0027 |
| 207 |
RENAL INJURY |
81 |
0.0027 |
| 208 |
PALPITATIONS |
319 |
0.0027 |
| 209 |
FEAR OF DEATH |
6 |
0.0027 |
| 210 |
RESTLESS LEGS SYNDROME |
48 |
0.0026 |
| 211 |
EYE SWELLING |
98 |
0.0026 |
| 212 |
ATRIOVENTRICULAR BLOCK |
20 |
0.0026 |
| 213 |
FLUID OVERLOAD |
37 |
0.0025 |
| 214 |
SKIN SWELLING |
22 |
0.0025 |
| 215 |
SKIN REACTION |
35 |
0.0025 |
| 216 |
DEVICE RELATED SEPSIS |
5 |
0.0025 |
| 217 |
WRONG DRUG ADMINISTERED |
22 |
0.0025 |
| 218 |
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS |
6 |
0.0024 |
| 219 |
CONDITION AGGRAVATED |
736 |
0.0024 |
| 220 |
HEART RATE INCREASED |
237 |
0.0024 |
| 221 |
SKIN EXFOLIATION |
201 |
0.0024 |
| 222 |
ABSCESS INTESTINAL |
5 |
0.0023 |
| 223 |
ACCIDENTAL EXPOSURE TO PRODUCT |
226 |
0.0022 |
| 224 |
HAIR DISORDER |
18 |
0.0022 |
| 225 |
NEURODERMATITIS |
8 |
0.0021 |
| 226 |
DISCOURAGEMENT |
5 |
0.0021 |
| 227 |
THROMBOSIS IN DEVICE |
7 |
0.0021 |
| 228 |
RENAL FAILURE |
282 |
0.0021 |
| 229 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
95 |
0.0021 |
| 230 |
HAEMORRHOIDS |
41 |
0.0021 |
| 231 |
RASH PAPULAR |
47 |
0.0021 |
| 232 |
PRODUCT ADMINISTRATION ERROR |
42 |
0.0021 |
| 233 |
DIALYSIS |
29 |
0.0020 |
| 234 |
HAEMODIALYSIS |
17 |
0.0020 |
| 235 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
111 |
0.0020 |
| 236 |
URINE ANALYSIS ABNORMAL |
6 |
0.0020 |
| 237 |
FOLLICULITIS |
21 |
0.0020 |
| 238 |
HEART RATE IRREGULAR |
45 |
0.0020 |
| 239 |
SKIN HYPERPIGMENTATION |
17 |
0.0020 |
| 240 |
CHEMICAL BURN OF SKIN |
5 |
0.0020 |
| 241 |
EXPOSURE VIA SKIN CONTACT |
51 |
0.0020 |
| 242 |
BLOOD PRESSURE FLUCTUATION |
47 |
0.0020 |
| 243 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
6 |
0.0019 |
| 244 |
VITREOUS FLOATERS |
19 |
0.0019 |
| 245 |
ROSACEA |
9 |
0.0019 |
| 246 |
SUICIDAL BEHAVIOUR |
8 |
0.0019 |
| 247 |
BASAL CELL CARCINOMA |
30 |
0.0019 |
| 248 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
17 |
0.0019 |
| 249 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
387 |
0.0019 |
| 250 |
SENSITIVE SKIN |
14 |
0.0019 |
| 251 |
INCORRECT DOSE ADMINISTERED |
431 |
0.0019 |
| 252 |
PULMONARY HYPERTENSION |
39 |
0.0019 |
| 253 |
VITAMIN D DECREASED |
16 |
0.0019 |
| 254 |
PRESYNCOPE |
45 |
0.0018 |
| 255 |
ANORGASMIA |
5 |
0.0018 |
| 256 |
EYE IRRITATION |
106 |
0.0018 |
| 257 |
BREAST ENLARGEMENT |
6 |
0.0018 |
| 258 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
11 |
0.0018 |
| 259 |
MELANOCYTIC NAEVUS |
8 |
0.0018 |
| 260 |
NEPHROPATHY |
17 |
0.0018 |
| 261 |
VENOUS THROMBOSIS |
7 |
0.0018 |
| 262 |
GENERALISED OEDEMA |
22 |
0.0018 |
| 263 |
DIABETIC RETINOPATHY |
6 |
0.0018 |
| 264 |
HEADACHE |
1103 |
0.0018 |
| 265 |
SOCIAL AVOIDANT BEHAVIOUR |
10 |
0.0017 |
| 266 |
ANHEDONIA |
45 |
0.0017 |
| 267 |
UMBILICAL HERNIA |
8 |
0.0017 |
| 268 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
5 |
0.0017 |
| 269 |
ACUTE CORONARY SYNDROME |
14 |
0.0017 |
| 270 |
SKIN WEEPING |
6 |
0.0017 |
| 271 |
OFF LABEL USE |
1459 |
0.0017 |
| 272 |
PRODUCT ADMINISTRATION INTERRUPTED |
13 |
0.0017 |
| 273 |
ENTEROCOCCAL INFECTION |
8 |
0.0017 |
| 274 |
AFFECTIVE DISORDER |
13 |
0.0017 |
| 275 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
10 |
0.0016 |
| 276 |
FACIAL PARALYSIS |
14 |
0.0016 |
| 277 |
HORMONE LEVEL ABNORMAL |
8 |
0.0016 |
| 278 |
BREAST MASS |
11 |
0.0016 |
| 279 |
DEAFNESS UNILATERAL |
9 |
0.0016 |
| 280 |
PROTEINURIA |
31 |
0.0016 |
| 281 |
TEARFULNESS |
7 |
0.0016 |
| 282 |
ACNE |
123 |
0.0016 |
| 283 |
DIASTOLIC DYSFUNCTION |
5 |
0.0016 |
| 284 |
CARDIAC FAILURE CONGESTIVE |
130 |
0.0016 |
| 285 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
11 |
0.0016 |
| 286 |
DIABETIC NEUROPATHY |
8 |
0.0016 |
| 287 |
HEPATIC STEATOSIS |
30 |
0.0016 |
| 288 |
CHEST PAIN |
298 |
0.0016 |
| 289 |
NEPHROTIC SYNDROME |
11 |
0.0016 |
| 290 |
ADVERSE REACTION |
21 |
0.0016 |
| 291 |
TROPONIN INCREASED |
12 |
0.0016 |
| 292 |
DERMATITIS |
33 |
0.0016 |
| 293 |
DRY SKIN |
210 |
0.0016 |
| 294 |
CONJUNCTIVAL HAEMORRHAGE |
6 |
0.0016 |
| 295 |
JOINT RANGE OF MOTION DECREASED |
21 |
0.0016 |
| 296 |
RASH |
668 |
0.0015 |
| 297 |
ACUTE KIDNEY INJURY |
234 |
0.0015 |
| 298 |
ACUTE MYOCARDIAL INFARCTION |
45 |
0.0015 |
| 299 |
SKIN ODOUR ABNORMAL |
6 |
0.0015 |
| 300 |
PNEUMONIA FUNGAL |
6 |
0.0015 |
| 301 |
ECONOMIC PROBLEM |
23 |
0.0015 |
| 302 |
DERMATITIS ALLERGIC |
19 |
0.0015 |
| 303 |
HYPERPHAGIA |
6 |
0.0015 |
| 304 |
SKIN PAPILLOMA |
6 |
0.0015 |
| 305 |
PERITONITIS BACTERIAL |
15 |
0.0015 |
| 306 |
SKIN DISORDER |
49 |
0.0015 |
| 307 |
ANGINA PECTORIS |
42 |
0.0015 |
| 308 |
APLASIA PURE RED CELL |
5 |
0.0015 |
| 309 |
EPSTEIN-BARR VIRUS INFECTION |
9 |
0.0014 |
| 310 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
31 |
0.0014 |
| 311 |
THERMAL BURN |
10 |
0.0014 |
| 312 |
CAROTID ARTERY OCCLUSION |
5 |
0.0014 |
| 313 |
DYSPHEMIA |
6 |
0.0014 |
| 314 |
INITIAL INSOMNIA |
14 |
0.0014 |
| 315 |
FACE OEDEMA |
23 |
0.0014 |
| 316 |
HAEMATOCRIT DECREASED |
27 |
0.0014 |
| 317 |
PERIPHERAL VASCULAR DISORDER |
7 |
0.0014 |
| 318 |
ARTERIOSCLEROSIS CORONARY ARTERY |
9 |
0.0014 |
| 319 |
BLOOD CREATINE INCREASED |
6 |
0.0014 |
| 320 |
HYPERTENSION |
287 |
0.0014 |
| 321 |
OEDEMA PERIPHERAL |
165 |
0.0014 |
| 322 |
PANIC ATTACK |
49 |
0.0013 |
| 323 |
POLYURIA |
11 |
0.0013 |
| 324 |
IRON DEFICIENCY |
6 |
0.0013 |
| 325 |
WRONG PRODUCT ADMINISTERED |
9 |
0.0013 |
| 326 |
BODY TEMPERATURE DECREASED |
13 |
0.0013 |
| 327 |
PULMONARY OEDEMA |
59 |
0.0013 |
| 328 |
PRODUCT USE ISSUE |
247 |
0.0013 |
| 329 |
HYPERKALAEMIA |
46 |
0.0013 |
| 330 |
BLOOD PRESSURE ABNORMAL |
26 |
0.0013 |
| 331 |
FEAR |
35 |
0.0013 |
| 332 |
PLEURAL EFFUSION |
79 |
0.0013 |
| 333 |
PRODUCT RESIDUE PRESENT |
7 |
0.0013 |
| 334 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
22 |
0.0013 |
| 335 |
FORMICATION |
9 |
0.0013 |
| 336 |
EYELID OEDEMA |
15 |
0.0013 |
| 337 |
SCAR |
22 |
0.0013 |
| 338 |
DIZZINESS |
640 |
0.0013 |
| 339 |
ASTHENOPIA |
7 |
0.0013 |
| 340 |
SKIN DISCOLOURATION |
58 |
0.0013 |
| 341 |
DEPRESSION |
284 |
0.0012 |
| 342 |
PANIC REACTION |
9 |
0.0012 |
| 343 |
INCORRECT DRUG ADMINISTRATION DURATION |
35 |
0.0012 |
| 344 |
RASH VESICULAR |
6 |
0.0012 |
| 345 |
TUBULOINTERSTITIAL NEPHRITIS |
23 |
0.0012 |
| 346 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
21 |
0.0012 |
| 347 |
RED BLOOD CELL COUNT DECREASED |
35 |
0.0012 |
| 348 |
RENAL TUBULAR NECROSIS |
12 |
0.0012 |
| 349 |
CARDIOMEGALY |
15 |
0.0012 |
| 350 |
PSYCHIATRIC SYMPTOM |
9 |
0.0012 |
| 351 |
OEDEMA |
66 |
0.0012 |
| 352 |
SKIN ATROPHY |
7 |
0.0012 |
| 353 |
TACHYCARDIA |
108 |
0.0012 |
| 354 |
HYPERVOLAEMIA |
6 |
0.0012 |
| 355 |
ABDOMINAL TENDERNESS |
6 |
0.0012 |
| 356 |
ORTHOSTATIC HYPOTENSION |
21 |
0.0012 |
| 357 |
ECZEMA |
63 |
0.0012 |
| 358 |
RESTLESSNESS |
44 |
0.0012 |
| 359 |
CONGESTIVE CARDIOMYOPATHY |
5 |
0.0012 |
| 360 |
BREAST TENDERNESS |
9 |
0.0012 |
| 361 |
METABOLIC ACIDOSIS |
38 |
0.0012 |
| 362 |
SKIN PLAQUE |
10 |
0.0012 |
| 363 |
GLUCOSE TOLERANCE IMPAIRED |
7 |
0.0012 |
| 364 |
IMPAIRED QUALITY OF LIFE |
17 |
0.0012 |
| 365 |
BLOOD PRESSURE INCREASED |
180 |
0.0012 |
| 366 |
WEIGHT INCREASED |
263 |
0.0012 |
| 367 |
HYPERLIPIDAEMIA |
14 |
0.0012 |
| 368 |
ENDOCARDITIS |
6 |
0.0012 |
| 369 |
EAR DISCOMFORT |
12 |
0.0012 |
| 370 |
VERTIGO |
71 |
0.0012 |
| 371 |
TYPE 1 DIABETES MELLITUS |
7 |
0.0012 |
| 372 |
SKIN INFECTION |
13 |
0.0012 |
| 373 |
OCULAR DISCOMFORT |
13 |
0.0012 |
| 374 |
EYE INFLAMMATION |
11 |
0.0012 |
| 375 |
MYOCARDIAL ISCHAEMIA |
13 |
0.0011 |
| 376 |
FLUID RETENTION |
58 |
0.0011 |
| 377 |
GLOMERULAR FILTRATION RATE DECREASED |
14 |
0.0011 |
| 378 |
GROIN PAIN |
10 |
0.0011 |
| 379 |
SKIN BURNING SENSATION |
81 |
0.0011 |
| 380 |
ATRIAL FLUTTER |
9 |
0.0011 |
| 381 |
THINKING ABNORMAL |
21 |
0.0011 |
| 382 |
SINUS TACHYCARDIA |
16 |
0.0011 |
| 383 |
PERIPHERAL SWELLING |
173 |
0.0011 |
| 384 |
ARRHYTHMIA |
53 |
0.0011 |
| 385 |
MENTAL IMPAIRMENT |
27 |
0.0011 |
| 386 |
SWELLING |
104 |
0.0011 |
| 387 |
PHOTOPSIA |
7 |
0.0011 |
| 388 |
ANXIETY |
315 |
0.0011 |
| 389 |
CEREBRAL INFARCTION |
27 |
0.0011 |
| 390 |
PRURITUS |
424 |
0.0011 |
| 391 |
SLEEP APNOEA SYNDROME |
21 |
0.0011 |
| 392 |
NONSPECIFIC REACTION |
6 |
0.0011 |
| 393 |
ORAL DISORDER |
8 |
0.0011 |
| 394 |
HAEMOGLOBIN ABNORMAL |
7 |
0.0011 |
| 395 |
PERICARDITIS |
18 |
0.0011 |
| 396 |
ACUTE PULMONARY OEDEMA |
6 |
0.0011 |
| 397 |
GASTROOESOPHAGEAL REFLUX DISEASE |
86 |
0.0011 |
| 398 |
PRODUCT PREPARATION ISSUE |
7 |
0.0011 |
| 399 |
PHOTOPHOBIA |
20 |
0.0011 |
| 400 |
MOOD ALTERED |
29 |
0.0011 |
| 401 |
MIGRAINE |
101 |
0.0011 |
| 402 |
BLOOD CREATININE INCREASED |
69 |
0.0011 |
| 403 |
CHEST DISCOMFORT |
108 |
0.0011 |
| 404 |
NEUROLOGICAL SYMPTOM |
6 |
0.0010 |
| 405 |
PRODUCT PRESCRIBING ERROR |
25 |
0.0010 |
| 406 |
BOWEL MOVEMENT IRREGULARITY |
8 |
0.0010 |
| 407 |
CARDIAC MURMUR |
9 |
0.0010 |
| 408 |
DEVICE RELATED INFECTION |
16 |
0.0010 |
| 409 |
ATRIAL FIBRILLATION |
101 |
0.0010 |
| 410 |
GYNAECOMASTIA |
32 |
0.0010 |
| 411 |
BLISTER |
58 |
0.0010 |
| 412 |
STRESS CARDIOMYOPATHY |
6 |
0.0010 |
| 413 |
URINE OUTPUT DECREASED |
9 |
0.0010 |
| 414 |
CARDIO-RESPIRATORY ARREST |
43 |
0.0010 |
| 415 |
VITAMIN D DEFICIENCY |
10 |
0.0010 |
| 416 |
HAEMORRHAGIC STROKE |
8 |
0.0010 |
| 417 |
CORONARY ARTERY DISEASE |
31 |
0.0010 |
| 418 |
PRODUCT PREPARATION ERROR |
21 |
0.0010 |
| 419 |
DECREASED ACTIVITY |
11 |
0.0010 |
| 420 |
ELECTROCARDIOGRAM ABNORMAL |
8 |
0.0010 |
| 421 |
INTRAOCULAR PRESSURE INCREASED |
13 |
0.0010 |
| 422 |
BLOOD UREA INCREASED |
17 |
0.0010 |
| 423 |
ACCIDENTAL OVERDOSE |
37 |
0.0010 |
| 424 |
FACIAL PAIN |
9 |
0.0010 |
| 425 |
VISION BLURRED |
138 |
0.0010 |
| 426 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
25 |
0.0010 |
| 427 |
MUSCLE DISORDER |
8 |
0.0010 |
| 428 |
BURNING SENSATION |
69 |
0.0010 |
| 429 |
POST PROCEDURAL INFECTION |
8 |
0.0010 |
| 430 |
DEPRESSED MOOD |
52 |
0.0010 |
| 431 |
MITRAL VALVE INCOMPETENCE |
11 |
0.0010 |
| 432 |
PIGMENTATION DISORDER |
6 |
0.0010 |
| 433 |
SKIN ULCER |
25 |
0.0010 |
| 434 |
GASTROENTERITIS |
14 |
0.0010 |
| 435 |
HYPOTENSION |
192 |
0.0010 |
| 436 |
IMPAIRED GASTRIC EMPTYING |
13 |
0.0010 |
| 437 |
GOUT |
17 |
0.0009 |
| 438 |
FOREIGN BODY SENSATION IN EYES |
6 |
0.0009 |
| 439 |
INTENTIONAL PRODUCT USE ISSUE |
82 |
0.0009 |
| 440 |
ERYTHEMA |
192 |
0.0009 |
| 441 |
BLOOD PRESSURE DECREASED |
62 |
0.0009 |
| 442 |
DRUG EFFECT DECREASED |
50 |
0.0009 |
| 443 |
CARDIAC FLUTTER |
6 |
0.0009 |
| 444 |
URTICARIA |
155 |
0.0009 |
| 445 |
PRURITUS GENERALISED |
20 |
0.0009 |
| 446 |
CONTRAINDICATED PRODUCT ADMINISTERED |
28 |
0.0009 |
| 447 |
TENDON PAIN |
7 |
0.0009 |
| 448 |
TARDIVE DYSKINESIA |
26 |
0.0009 |
| 449 |
REFUSAL OF TREATMENT BY PATIENT |
6 |
0.0009 |
| 450 |
ASPIRATION |
10 |
0.0009 |
| 451 |
LUNG INFILTRATION |
8 |
0.0009 |
| 452 |
APPETITE DISORDER |
6 |
0.0009 |
| 453 |
BLOOD SODIUM DECREASED |
17 |
0.0009 |
| 454 |
PELVIC FRACTURE |
7 |
0.0009 |
| 455 |
ATRIOVENTRICULAR BLOCK COMPLETE |
6 |
0.0009 |
| 456 |
SUICIDAL IDEATION |
82 |
0.0009 |
| 457 |
HYPOAESTHESIA |
134 |
0.0009 |
| 458 |
TINNITUS |
41 |
0.0009 |
| 459 |
POSTOPERATIVE WOUND INFECTION |
6 |
0.0009 |
| 460 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
26 |
0.0009 |
| 461 |
EYELID PTOSIS |
9 |
0.0009 |
| 462 |
PARAESTHESIA |
139 |
0.0009 |
| 463 |
NASAL DISCOMFORT |
7 |
0.0009 |
| 464 |
SLUGGISHNESS |
9 |
0.0009 |
| 465 |
TRICUSPID VALVE INCOMPETENCE |
7 |
0.0009 |
| 466 |
RENAL IMPAIRMENT |
74 |
0.0009 |
| 467 |
CARDIOMYOPATHY |
13 |
0.0009 |
| 468 |
DYSPNOEA EXERTIONAL |
33 |
0.0009 |
| 469 |
IMMUNODEFICIENCY |
13 |
0.0009 |
| 470 |
BLOOD PRESSURE SYSTOLIC INCREASED |
17 |
0.0009 |
| 471 |
CORONARY ARTERY BYPASS |
5 |
0.0009 |
| 472 |
PERITONITIS |
18 |
0.0009 |
| 473 |
NIGHT SWEATS |
28 |
0.0009 |
| 474 |
EYE DISCHARGE |
9 |
0.0009 |
| 475 |
BLOOD URIC ACID INCREASED |
5 |
0.0009 |
| 476 |
MADAROSIS |
10 |
0.0009 |
| 477 |
POOR QUALITY PRODUCT ADMINISTERED |
9 |
0.0009 |
| 478 |
PHOTOSENSITIVITY REACTION |
14 |
0.0008 |
| 479 |
MEDICATION ERROR |
47 |
0.0008 |
| 480 |
BREAST PAIN |
9 |
0.0008 |
| 481 |
TENDONITIS |
13 |
0.0008 |
| 482 |
FEELING JITTERY |
16 |
0.0008 |
| 483 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
6 |
0.0008 |
| 484 |
CARDIAC DISORDER |
78 |
0.0008 |
| 485 |
POST PROCEDURAL COMPLICATION |
16 |
0.0008 |
| 486 |
MENINGIOMA |
13 |
0.0008 |
| 487 |
SINUS BRADYCARDIA |
8 |
0.0008 |
| 488 |
LACRIMATION INCREASED |
25 |
0.0008 |
| 489 |
RENAL FAILURE ACUTE |
35 |
0.0008 |
| 490 |
PERITONEAL DIALYSIS COMPLICATION |
6 |
0.0008 |
| 491 |
EAR PAIN |
16 |
0.0008 |
| 492 |
APATHY |
12 |
0.0008 |
| 493 |
QUALITY OF LIFE DECREASED |
11 |
0.0008 |
| 494 |
ASCITES |
24 |
0.0008 |
| 495 |
MOOD SWINGS |
26 |
0.0008 |
| 496 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
58 |
0.0008 |
| 497 |
EYE PAIN |
46 |
0.0008 |
| 498 |
DYSURIA |
30 |
0.0008 |
| 499 |
LIP SWELLING |
27 |
0.0008 |
| 500 |
BRADYCARDIA |
43 |
0.0008 |
| 501 |
NERVE INJURY |
9 |
0.0008 |
| 502 |
HAEMOGLOBIN DECREASED |
83 |
0.0008 |
| 503 |
EYE PRURITUS |
27 |
0.0008 |
| 504 |
OCULAR HYPERAEMIA |
38 |
0.0008 |
| 505 |
SWOLLEN TONGUE |
25 |
0.0008 |
| 506 |
RETCHING |
17 |
0.0008 |
| 507 |
PAROSMIA |
6 |
0.0008 |
| 508 |
MENTAL STATUS CHANGES |
22 |
0.0008 |
| 509 |
NO ADVERSE EVENT |
142 |
0.0008 |
| 510 |
NASAL CONGESTION |
46 |
0.0008 |
| 511 |
SPEECH DISORDER |
41 |
0.0008 |
| 512 |
DRY EYE |
39 |
0.0008 |
| 513 |
MYOSITIS |
7 |
0.0008 |
| 514 |
HAEMOLYSIS |
6 |
0.0008 |
| 515 |
CONCUSSION |
6 |
0.0008 |
| 516 |
VENTRICULAR EXTRASYSTOLES |
8 |
0.0008 |
| 517 |
DIPLOPIA |
20 |
0.0008 |
| 518 |
ANGINA UNSTABLE |
5 |
0.0008 |
| 519 |
SUBDURAL HAEMATOMA |
11 |
0.0008 |
| 520 |
ORAL HERPES |
15 |
0.0008 |
| 521 |
RETINAL DETACHMENT |
7 |
0.0008 |
| 522 |
BLINDNESS |
31 |
0.0008 |
| 523 |
GASTRITIS |
20 |
0.0008 |
| 524 |
ANOSMIA |
11 |
0.0008 |
| 525 |
BLOOD IRON DECREASED |
9 |
0.0008 |
| 526 |
IRON DEFICIENCY ANAEMIA |
7 |
0.0008 |
| 527 |
FURUNCLE |
6 |
0.0008 |
| 528 |
ABORTION INDUCED |
7 |
0.0007 |
| 529 |
PAIN OF SKIN |
20 |
0.0007 |
| 530 |
NOCTURIA |
9 |
0.0007 |
| 531 |
INSOMNIA |
197 |
0.0007 |
| 532 |
DERMATITIS ATOPIC |
39 |
0.0007 |
| 533 |
HEAD DISCOMFORT |
13 |
0.0007 |
| 534 |
NECK PAIN |
41 |
0.0007 |
| 535 |
PRODUCT USE IN UNAPPROVED INDICATION |
181 |
0.0007 |
| 536 |
LETHARGY |
42 |
0.0007 |
| 537 |
SKIN LESION |
20 |
0.0007 |
| 538 |
UPPER-AIRWAY COUGH SYNDROME |
6 |
0.0007 |
| 539 |
COGNITIVE DISORDER |
34 |
0.0007 |
| 540 |
VENTRICULAR TACHYCARDIA |
12 |
0.0007 |
| 541 |
TOOTH FRACTURE |
8 |
0.0007 |
| 542 |
DIZZINESS POSTURAL |
7 |
0.0007 |
| 543 |
AGEUSIA |
18 |
0.0007 |
| 544 |
SECRETION DISCHARGE |
9 |
0.0007 |
| 545 |
SKIN FISSURES |
14 |
0.0007 |
| 546 |
NEPHROPATHY TOXIC |
8 |
0.0007 |
| 547 |
MUSCLE ATROPHY |
9 |
0.0007 |
| 548 |
LIGAMENT SPRAIN |
7 |
0.0007 |
| 549 |
DISCOMFORT |
43 |
0.0007 |
| 550 |
INTENTIONAL DOSE OMISSION |
20 |
0.0007 |
| 551 |
HYPOTONIA |
7 |
0.0007 |
| 552 |
CONJUNCTIVITIS |
13 |
0.0007 |
| 553 |
PRODUCT CONTAINER ISSUE |
6 |
0.0007 |
| 554 |
MYOCARDITIS |
8 |
0.0007 |
| 555 |
SHOCK |
16 |
0.0007 |
| 556 |
HIATUS HERNIA |
9 |
0.0007 |
| 557 |
RESPIRATORY TRACT CONGESTION |
11 |
0.0007 |
| 558 |
ULCER |
11 |
0.0007 |
| 559 |
DRY THROAT |
7 |
0.0007 |
| 560 |
SUBARACHNOID HAEMORRHAGE |
7 |
0.0007 |
| 561 |
C-REACTIVE PROTEIN INCREASED |
25 |
0.0007 |
| 562 |
JOINT STIFFNESS |
18 |
0.0007 |
| 563 |
SENSORY DISTURBANCE |
11 |
0.0007 |
| 564 |
TEMPERATURE INTOLERANCE |
7 |
0.0007 |
| 565 |
BLINDNESS TRANSIENT |
5 |
0.0007 |
| 566 |
THIRST |
12 |
0.0007 |
| 567 |
JOINT SWELLING |
81 |
0.0007 |
| 568 |
SYNCOPE |
67 |
0.0007 |
| 569 |
DYSPNOEA |
379 |
0.0007 |
| 570 |
RASH ERYTHEMATOUS |
32 |
0.0007 |
| 571 |
THERAPEUTIC RESPONSE UNEXPECTED |
30 |
0.0007 |
| 572 |
ANAL INCONTINENCE |
6 |
0.0007 |
| 573 |
PSORIASIS |
87 |
0.0007 |
| 574 |
RENAL DISORDER |
31 |
0.0007 |
| 575 |
DYSARTHRIA |
25 |
0.0007 |
| 576 |
TACHYPNOEA |
9 |
0.0007 |
| 577 |
ADVERSE EVENT |
61 |
0.0007 |
| 578 |
RENAL PAIN |
7 |
0.0007 |
| 579 |
FUNGAL INFECTION |
22 |
0.0007 |
| 580 |
DYSGEUSIA |
49 |
0.0007 |
| 581 |
OSTEOPENIA |
10 |
0.0007 |
| 582 |
AORTIC ANEURYSM |
5 |
0.0007 |
| 583 |
DISEASE RECURRENCE |
31 |
0.0007 |
| 584 |
UROSEPSIS |
6 |
0.0006 |
| 585 |
INTERVERTEBRAL DISC DEGENERATION |
6 |
0.0006 |
| 586 |
EJECTION FRACTION DECREASED |
10 |
0.0006 |
| 587 |
PRODUCT DISPENSING ERROR |
14 |
0.0006 |
| 588 |
ABDOMINAL DISTENSION |
67 |
0.0006 |
| 589 |
THERAPY PARTIAL RESPONDER |
10 |
0.0006 |
| 590 |
OESOPHAGITIS |
7 |
0.0006 |
| 591 |
FLANK PAIN |
6 |
0.0006 |
| 592 |
MULTI-ORGAN FAILURE |
11 |
0.0006 |
| 593 |
GASTROINTESTINAL PAIN |
7 |
0.0006 |
| 594 |
SEASONAL ALLERGY |
9 |
0.0006 |
| 595 |
DENTAL CARIES |
7 |
0.0006 |
| 596 |
BLOOD ALBUMIN DECREASED |
5 |
0.0006 |
| 597 |
RASH MACULAR |
22 |
0.0006 |
| 598 |
MALNUTRITION |
7 |
0.0006 |
| 599 |
COLD SWEAT |
11 |
0.0006 |
| 600 |
ACUTE RESPIRATORY FAILURE |
12 |
0.0006 |
| 601 |
GLAUCOMA |
12 |
0.0006 |
| 602 |
LOCALISED INFECTION |
15 |
0.0006 |
| 603 |
ERUCTATION |
12 |
0.0006 |
| 604 |
OVERDOSE |
133 |
0.0006 |
| 605 |
THROMBOTIC MICROANGIOPATHY |
6 |
0.0006 |
| 606 |
DECUBITUS ULCER |
5 |
0.0006 |
| 607 |
PHARYNGEAL SWELLING |
6 |
0.0006 |
| 608 |
MICTURITION URGENCY |
7 |
0.0006 |
| 609 |
INTERNAL HAEMORRHAGE |
7 |
0.0006 |
| 610 |
CONVULSION |
35 |
0.0006 |
| 611 |
THERAPY CHANGE |
6 |
0.0006 |
| 612 |
LEUKOCYTOSIS |
11 |
0.0006 |
| 613 |
BONE DISORDER |
11 |
0.0006 |
| 614 |
PAIN IN JAW |
17 |
0.0006 |
| 615 |
COMPLETED SUICIDE |
50 |
0.0006 |
| 616 |
MYALGIA |
102 |
0.0006 |
| 617 |
SLEEP DISORDER |
42 |
0.0006 |
| 618 |
HEMIPARESIS |
10 |
0.0006 |
| 619 |
ANGIOEDEMA |
26 |
0.0006 |
| 620 |
EUPHORIC MOOD |
6 |
0.0006 |
| 621 |
THYROID DISORDER |
9 |
0.0006 |
| 622 |
CORONARY ARTERY OCCLUSION |
8 |
0.0006 |
| 623 |
IRRITABILITY |
35 |
0.0006 |
| 624 |
UNRESPONSIVE TO STIMULI |
15 |
0.0006 |
| 625 |
ANURIA |
5 |
0.0006 |
| 626 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
8 |
0.0006 |
| 627 |
AGGRESSION |
29 |
0.0006 |
| 628 |
BLOOD MAGNESIUM DECREASED |
5 |
0.0006 |
| 629 |
DIVERTICULITIS |
16 |
0.0006 |
| 630 |
STAPHYLOCOCCAL INFECTION |
19 |
0.0006 |
| 631 |
DEAFNESS |
15 |
0.0006 |
| 632 |
KNEE ARTHROPLASTY |
12 |
0.0006 |
| 633 |
HYPOXIA |
20 |
0.0006 |
| 634 |
FEELING ABNORMAL |
136 |
0.0006 |
| 635 |
TREATMENT NONCOMPLIANCE |
31 |
0.0006 |
| 636 |
OBESITY |
9 |
0.0006 |
| 637 |
VISUAL IMPAIRMENT |
70 |
0.0006 |
| 638 |
CYST |
7 |
0.0006 |
| 639 |
EAR INFECTION |
15 |
0.0006 |
| 640 |
APHASIA |
17 |
0.0006 |
| 641 |
POOR QUALITY SLEEP |
12 |
0.0006 |
| 642 |
DISTURBANCE IN ATTENTION |
30 |
0.0006 |
| 643 |
HAEMATEMESIS |
14 |
0.0006 |
| 644 |
MYOCARDIAL INFARCTION |
96 |
0.0005 |
| 645 |
THROMBOSIS |
44 |
0.0005 |
| 646 |
EMOTIONAL DISTRESS |
66 |
0.0005 |
| 647 |
THERAPEUTIC RESPONSE DECREASED |
33 |
0.0005 |
| 648 |
RESPIRATORY DISTRESS |
15 |
0.0005 |
| 649 |
COAGULOPATHY |
9 |
0.0005 |
| 650 |
PLATELET COUNT INCREASED |
7 |
0.0005 |
| 651 |
LYMPHADENOPATHY |
19 |
0.0005 |
| 652 |
MUSCULAR WEAKNESS |
61 |
0.0005 |
| 653 |
NODULE |
7 |
0.0005 |
| 654 |
POLLAKIURIA |
22 |
0.0005 |
| 655 |
TOXIC EPIDERMAL NECROLYSIS |
8 |
0.0005 |
| 656 |
INJURY |
37 |
0.0005 |
| 657 |
ABASIA |
13 |
0.0005 |
| 658 |
CONFUSIONAL STATE |
85 |
0.0005 |
| 659 |
NEOPLASM |
6 |
0.0005 |
| 660 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
25 |
0.0005 |
| 661 |
HYPERHIDROSIS |
67 |
0.0005 |
| 662 |
UPPER RESPIRATORY TRACT INFECTION |
24 |
0.0005 |
| 663 |
ATELECTASIS |
5 |
0.0005 |
| 664 |
PRODUCT TASTE ABNORMAL |
7 |
0.0005 |
| 665 |
PRODUCT DOSE OMISSION ISSUE |
152 |
0.0005 |
| 666 |
RASH PRURITIC |
28 |
0.0005 |
| 667 |
EOSINOPHILIA |
9 |
0.0005 |
| 668 |
AUTOIMMUNE DISORDER |
5 |
0.0005 |
| 669 |
CARDIOVASCULAR DISORDER |
13 |
0.0005 |
| 670 |
SURGERY |
30 |
0.0005 |
| 671 |
CEREBROVASCULAR ACCIDENT |
86 |
0.0005 |
| 672 |
THERAPY CESSATION |
26 |
0.0005 |
| 673 |
BACTERAEMIA |
6 |
0.0005 |
| 674 |
ISCHAEMIC STROKE |
9 |
0.0005 |
| 675 |
NAUSEA |
399 |
0.0005 |
| 676 |
ANAEMIA |
96 |
0.0005 |
| 677 |
PRODUCTIVE COUGH |
24 |
0.0005 |
| 678 |
GASTROINTESTINAL HAEMORRHAGE |
42 |
0.0005 |
| 679 |
ADRENAL INSUFFICIENCY |
6 |
0.0005 |
| 680 |
PRODUCT DOSE OMISSION IN ERROR |
14 |
0.0005 |
| 681 |
MUSCLE TIGHTNESS |
8 |
0.0005 |
| 682 |
FLATULENCE |
28 |
0.0005 |
| 683 |
NEURALGIA |
12 |
0.0005 |
| 684 |
VOMITING |
231 |
0.0005 |
| 685 |
HOT FLUSH |
37 |
0.0005 |
| 686 |
THROAT IRRITATION |
22 |
0.0005 |
| 687 |
PANCREATITIS ACUTE |
11 |
0.0005 |
| 688 |
ASTHENIA |
184 |
0.0005 |
| 689 |
UNEVALUABLE EVENT |
37 |
0.0005 |
| 690 |
DRUG ADMINISTRATION ERROR |
15 |
0.0005 |
| 691 |
BLOOD GLUCOSE ABNORMAL |
9 |
0.0005 |
| 692 |
URINARY TRACT INFECTION |
83 |
0.0005 |
| 693 |
EMOTIONAL DISORDER |
15 |
0.0005 |
| 694 |
COVID-19 |
85 |
0.0005 |
| 695 |
FATIGUE |
377 |
0.0005 |
| 696 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
12 |
0.0005 |
| 697 |
FLUSHING |
49 |
0.0005 |
| 698 |
MIDDLE INSOMNIA |
9 |
0.0005 |
| 699 |
THROAT TIGHTNESS |
13 |
0.0005 |
| 700 |
INTENTIONAL PRODUCT MISUSE |
42 |
0.0005 |
| 701 |
RHINORRHOEA |
31 |
0.0005 |
| 702 |
NERVOUSNESS |
25 |
0.0005 |
| 703 |
AMNESIA |
31 |
0.0005 |
| 704 |
TYPE 2 DIABETES MELLITUS |
16 |
0.0005 |
| 705 |
TRANSIENT ISCHAEMIC ATTACK |
16 |
0.0005 |
| 706 |
MOBILITY DECREASED |
34 |
0.0005 |
| 707 |
ABDOMINAL PAIN |
110 |
0.0005 |
| 708 |
COUGH |
132 |
0.0005 |
| 709 |
DRUG EFFECT INCOMPLETE |
17 |
0.0005 |
| 710 |
EPISTAXIS |
35 |
0.0005 |
| 711 |
IMPAIRED WORK ABILITY |
10 |
0.0005 |
| 712 |
DYSPEPSIA |
46 |
0.0005 |
| 713 |
IRRITABLE BOWEL SYNDROME |
10 |
0.0005 |
| 714 |
BLOOD POTASSIUM DECREASED |
14 |
0.0005 |
| 715 |
ANOREXIA |
6 |
0.0005 |
| 716 |
RECTAL HAEMORRHAGE |
20 |
0.0005 |
| 717 |
MUSCULOSKELETAL DISCOMFORT |
8 |
0.0005 |
| 718 |
OROPHARYNGEAL PAIN |
43 |
0.0005 |
| 719 |
ARTHRALGIA |
193 |
0.0005 |
| 720 |
HAEMATOMA |
12 |
0.0005 |
| 721 |
OSTEOPOROSIS |
19 |
0.0005 |
| 722 |
MENTAL DISORDER |
20 |
0.0005 |
| 723 |
BRONCHITIS |
34 |
0.0005 |
| 724 |
LOCAL SWELLING |
8 |
0.0005 |
| 725 |
INSURANCE ISSUE |
7 |
0.0005 |
| 726 |
FEELING HOT |
28 |
0.0005 |
| 727 |
ILLNESS |
47 |
0.0005 |
| 728 |
PULMONARY CONGESTION |
6 |
0.0005 |
| 729 |
PHARYNGEAL OEDEMA |
7 |
0.0005 |
| 730 |
SINUS DISORDER |
9 |
0.0005 |
| 731 |
MELAENA |
10 |
0.0005 |
| 732 |
HYPOGLYCAEMIA |
22 |
0.0005 |
| 733 |
BLOOD TRIGLYCERIDES INCREASED |
8 |
0.0005 |
| 734 |
RESPIRATORY FAILURE |
33 |
0.0005 |
| 735 |
BACK PAIN |
105 |
0.0005 |
| 736 |
LIVER DISORDER |
20 |
0.0005 |
| 737 |
STEVENS-JOHNSON SYNDROME |
10 |
0.0004 |
| 738 |
GENERAL PHYSICAL HEALTH DETERIORATION |
52 |
0.0004 |
| 739 |
STOMATITIS |
27 |
0.0004 |
| 740 |
WEIGHT DECREASED |
124 |
0.0004 |
| 741 |
FEEDING DISORDER |
9 |
0.0004 |
| 742 |
DRY MOUTH |
36 |
0.0004 |
| 743 |
TASTE DISORDER |
9 |
0.0004 |
| 744 |
GASTROENTERITIS VIRAL |
8 |
0.0004 |
| 745 |
CHROMATURIA |
10 |
0.0004 |
| 746 |
HEAD INJURY |
14 |
0.0004 |
| 747 |
CONSTIPATION |
96 |
0.0004 |
| 748 |
CARDIAC ARREST |
36 |
0.0004 |
| 749 |
CARDIAC FAILURE |
35 |
0.0004 |
| 750 |
AGITATION |
32 |
0.0004 |
| 751 |
HIP FRACTURE |
14 |
0.0004 |
| 752 |
RESPIRATORY DISORDER |
13 |
0.0004 |
| 753 |
MUSCLE TWITCHING |
10 |
0.0004 |
| 754 |
FEELING COLD |
12 |
0.0004 |
| 755 |
INTENTIONAL DRUG MISUSE |
9 |
0.0004 |
| 756 |
MASS |
6 |
0.0004 |
| 757 |
BLOOD CHOLESTEROL INCREASED |
20 |
0.0004 |
| 758 |
OXYGEN SATURATION DECREASED |
24 |
0.0004 |
| 759 |
BLOOD TEST ABNORMAL |
6 |
0.0004 |
| 760 |
CHOLELITHIASIS |
14 |
0.0004 |
| 761 |
OSTEOARTHRITIS |
18 |
0.0004 |
| 762 |
RESPIRATORY TRACT INFECTION |
11 |
0.0004 |
| 763 |
SOMNOLENCE |
85 |
0.0004 |
| 764 |
PAIN |
259 |
0.0004 |
| 765 |
BLOOD URINE PRESENT |
8 |
0.0004 |
| 766 |
HAEMORRHAGE |
44 |
0.0004 |
| 767 |
MUSCULOSKELETAL PAIN |
22 |
0.0004 |
| 768 |
CHOLECYSTITIS |
5 |
0.0004 |
| 769 |
CELLULITIS |
21 |
0.0004 |
| 770 |
LOWER LIMB FRACTURE |
8 |
0.0004 |
| 771 |
PARAESTHESIA ORAL |
6 |
0.0004 |
| 772 |
INFECTION |
60 |
0.0004 |
| 773 |
HYPERTHYROIDISM |
6 |
0.0004 |
| 774 |
HERNIA |
8 |
0.0004 |
| 775 |
SINUSITIS |
42 |
0.0004 |
| 776 |
INFLAMMATION |
21 |
0.0004 |
| 777 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
9 |
0.0004 |
| 778 |
SKIN HAEMORRHAGE |
6 |
0.0004 |
| 779 |
ABNORMAL WEIGHT GAIN |
5 |
0.0004 |
| 780 |
NIGHTMARE |
14 |
0.0004 |
| 781 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
8 |
0.0004 |
| 782 |
TREMOR |
67 |
0.0004 |
| 783 |
SEPSIS |
45 |
0.0004 |
| 784 |
GASTROINTESTINAL DISORDER |
36 |
0.0004 |
| 785 |
NEUROPATHY PERIPHERAL |
38 |
0.0004 |
| 786 |
PRODUCT SUBSTITUTION ISSUE |
23 |
0.0004 |
| 787 |
AMENORRHOEA |
7 |
0.0004 |
| 788 |
ABDOMINAL PAIN UPPER |
82 |
0.0004 |
| 789 |
HYPOAESTHESIA ORAL |
6 |
0.0004 |
| 790 |
PRODUCT PHYSICAL ISSUE |
8 |
0.0004 |
| 791 |
ASPARTATE AMINOTRANSFERASE INCREASED |
21 |
0.0004 |
| 792 |
HYPOACUSIS |
17 |
0.0004 |
| 793 |
CONTUSION |
38 |
0.0004 |
| 794 |
PRODUCT COMPLAINT |
10 |
0.0004 |
| 795 |
DIARRHOEA |
254 |
0.0004 |
| 796 |
NEPHROLITHIASIS |
18 |
0.0004 |
| 797 |
WHITE BLOOD CELL COUNT INCREASED |
15 |
0.0004 |
| 798 |
ALANINE AMINOTRANSFERASE INCREASED |
24 |
0.0004 |
| 799 |
RIB FRACTURE |
8 |
0.0004 |
| 800 |
MALAISE |
170 |
0.0004 |
| 801 |
ANKLE FRACTURE |
6 |
0.0004 |
| 802 |
OSTEOMYELITIS |
7 |
0.0004 |
| 803 |
INTERNATIONAL NORMALISED RATIO INCREASED |
11 |
0.0004 |
| 804 |
NERVOUS SYSTEM DISORDER |
12 |
0.0004 |
| 805 |
CHILLS |
45 |
0.0004 |
| 806 |
PNEUMONIA |
124 |
0.0004 |
| 807 |
LOSS OF CONSCIOUSNESS |
49 |
0.0004 |
| 808 |
MUSCLE SPASMS |
70 |
0.0004 |
| 809 |
DIABETES MELLITUS |
29 |
0.0004 |
| 810 |
HAEMATURIA |
13 |
0.0004 |
| 811 |
ABSCESS |
6 |
0.0004 |
| 812 |
HYPOTHYROIDISM |
12 |
0.0004 |
| 813 |
EATING DISORDER |
8 |
0.0004 |
| 814 |
PSYCHOTIC DISORDER |
11 |
0.0004 |
| 815 |
LACTIC ACIDOSIS |
12 |
0.0004 |
| 816 |
DECREASED APPETITE |
86 |
0.0004 |
| 817 |
HYPOCALCAEMIA |
7 |
0.0004 |
| 818 |
FAECES DISCOLOURED |
8 |
0.0004 |
| 819 |
GASTRIC ULCER |
7 |
0.0004 |
| 820 |
PRODUCT PRESCRIBING ISSUE |
8 |
0.0004 |
| 821 |
INJECTION SITE URTICARIA |
9 |
0.0004 |
| 822 |
INCREASED APPETITE |
7 |
0.0004 |
| 823 |
MULTIPLE FRACTURES |
6 |
0.0004 |
| 824 |
EYE DISORDER |
12 |
0.0004 |
| 825 |
DRUG PRESCRIBING ERROR |
7 |
0.0004 |
| 826 |
MEMORY IMPAIRMENT |
50 |
0.0004 |
| 827 |
CEREBRAL HAEMORRHAGE |
13 |
0.0004 |
| 828 |
RESPIRATORY ARREST |
10 |
0.0004 |
| 829 |
VIRAL INFECTION |
12 |
0.0004 |
| 830 |
DYSPHONIA |
21 |
0.0004 |
| 831 |
BONE PAIN |
21 |
0.0004 |
| 832 |
WOUND |
10 |
0.0004 |
| 833 |
CARPAL TUNNEL SYNDROME |
5 |
0.0004 |
| 834 |
THERAPY NON-RESPONDER |
16 |
0.0004 |
| 835 |
ABDOMINAL PAIN LOWER |
9 |
0.0004 |
| 836 |
BLINDNESS UNILATERAL |
5 |
0.0004 |
| 837 |
DISORIENTATION |
14 |
0.0004 |
| 838 |
CATARACT |
21 |
0.0004 |
| 839 |
DEHYDRATION |
47 |
0.0004 |
| 840 |
HEPATIC ENZYME INCREASED |
24 |
0.0004 |
| 841 |
PAIN IN EXTREMITY |
103 |
0.0003 |
| 842 |
CARDIOGENIC SHOCK |
5 |
0.0003 |
| 843 |
GAIT DISTURBANCE |
66 |
0.0003 |
| 844 |
BODY TEMPERATURE INCREASED |
7 |
0.0003 |
| 845 |
MUSCULOSKELETAL STIFFNESS |
30 |
0.0003 |
| 846 |
ARTHROPATHY |
19 |
0.0003 |
| 847 |
WHITE BLOOD CELL COUNT DECREASED |
37 |
0.0003 |
| 848 |
PANCYTOPENIA |
19 |
0.0003 |
| 849 |
HOSPITALISATION |
52 |
0.0003 |
| 850 |
TOOTH LOSS |
7 |
0.0003 |
| 851 |
JAUNDICE |
9 |
0.0003 |
| 852 |
BLOOD GLUCOSE DECREASED |
16 |
0.0003 |
| 853 |
HALLUCINATION, VISUAL |
7 |
0.0003 |
| 854 |
VISUAL ACUITY REDUCED |
11 |
0.0003 |
| 855 |
ARTHRITIS |
26 |
0.0003 |
| 856 |
JOINT INJURY |
7 |
0.0003 |
| 857 |
ASTHMA |
37 |
0.0003 |
| 858 |
INJECTION SITE RASH |
10 |
0.0003 |
| 859 |
ANGER |
11 |
0.0003 |
| 860 |
HYPOKALAEMIA |
15 |
0.0003 |
| 861 |
BALANCE DISORDER |
28 |
0.0003 |
| 862 |
LIMB DISCOMFORT |
10 |
0.0003 |
| 863 |
ALTERED STATE OF CONSCIOUSNESS |
7 |
0.0003 |
| 864 |
ABDOMINAL DISCOMFORT |
54 |
0.0003 |
| 865 |
BACTERIAL INFECTION |
6 |
0.0003 |
| 866 |
INTERVERTEBRAL DISC PROTRUSION |
7 |
0.0003 |
| 867 |
INTESTINAL OBSTRUCTION |
12 |
0.0003 |
| 868 |
CYSTITIS |
10 |
0.0003 |
| 869 |
HYPERSOMNIA |
9 |
0.0003 |
| 870 |
INJECTION SITE PRURITUS |
21 |
0.0003 |
| 871 |
GLOSSODYNIA |
7 |
0.0003 |
| 872 |
HEPATITIS |
8 |
0.0003 |
| 873 |
PYREXIA |
108 |
0.0003 |
| 874 |
DRUG INTERACTION |
49 |
0.0003 |
| 875 |
PHARMACEUTICAL PRODUCT COMPLAINT |
8 |
0.0003 |
| 876 |
CHOKING |
6 |
0.0003 |
| 877 |
PRODUCT AVAILABILITY ISSUE |
7 |
0.0003 |
| 878 |
LUNG DISORDER |
15 |
0.0003 |
| 879 |
KIDNEY INFECTION |
6 |
0.0003 |
| 880 |
PULMONARY EMBOLISM |
29 |
0.0003 |
| 881 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
11 |
0.0003 |
| 882 |
PANCREATITIS |
16 |
0.0003 |
| 883 |
INJECTION SITE BRUISING |
24 |
0.0003 |
| 884 |
INJECTION SITE SWELLING |
23 |
0.0003 |
| 885 |
URINARY RETENTION |
10 |
0.0003 |
| 886 |
HEPATIC FAILURE |
9 |
0.0003 |
| 887 |
FREQUENT BOWEL MOVEMENTS |
8 |
0.0003 |
| 888 |
CANDIDA INFECTION |
5 |
0.0003 |
| 889 |
THERAPY INTERRUPTED |
21 |
0.0003 |
| 890 |
DIABETIC KETOACIDOSIS |
7 |
0.0003 |
| 891 |
TREATMENT FAILURE |
24 |
0.0003 |
| 892 |
PROCEDURAL PAIN |
8 |
0.0003 |
| 893 |
RHABDOMYOLYSIS |
12 |
0.0003 |
| 894 |
WHEEZING |
17 |
0.0003 |
| 895 |
DEMENTIA |
8 |
0.0003 |
| 896 |
DEVICE USE ISSUE |
5 |
0.0003 |
| 897 |
WITHDRAWAL SYNDROME |
12 |
0.0003 |
| 898 |
ENCEPHALOPATHY |
7 |
0.0003 |
| 899 |
DYSPHAGIA |
27 |
0.0003 |
| 900 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
10 |
0.0003 |
| 901 |
BLOOD GLUCOSE INCREASED |
53 |
0.0003 |
| 902 |
PRODUCT ADHESION ISSUE |
10 |
0.0003 |
| 903 |
FALL |
92 |
0.0003 |
| 904 |
HYPERGLYCAEMIA |
10 |
0.0003 |
| 905 |
TOXICITY TO VARIOUS AGENTS |
46 |
0.0003 |
| 906 |
DRUG RESISTANCE |
7 |
0.0003 |
| 907 |
PSORIATIC ARTHROPATHY |
11 |
0.0003 |
| 908 |
DYSKINESIA |
11 |
0.0003 |
| 909 |
URINARY INCONTINENCE |
8 |
0.0003 |
| 910 |
TRANSAMINASES INCREASED |
6 |
0.0003 |
| 911 |
TOOTH DISORDER |
6 |
0.0003 |
| 912 |
COLITIS |
10 |
0.0003 |
| 913 |
ROAD TRAFFIC ACCIDENT |
11 |
0.0003 |
| 914 |
NASOPHARYNGITIS |
48 |
0.0003 |
| 915 |
NEOPLASM MALIGNANT |
17 |
0.0003 |
| 916 |
DISABILITY |
5 |
0.0003 |
| 917 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
10 |
0.0003 |
| 918 |
COMA |
12 |
0.0003 |
| 919 |
INFLUENZA |
28 |
0.0003 |
| 920 |
THROMBOCYTOPENIA |
28 |
0.0003 |
| 921 |
INJECTION SITE ERYTHEMA |
31 |
0.0002 |
| 922 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
13 |
0.0002 |
| 923 |
HYPONATRAEMIA |
14 |
0.0002 |
| 924 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
7 |
0.0002 |
| 925 |
COLITIS ULCERATIVE |
11 |
0.0002 |
| 926 |
LIVER INJURY |
6 |
0.0002 |
| 927 |
IMPAIRED HEALING |
8 |
0.0002 |
| 928 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
7 |
0.0002 |
| 929 |
THERAPEUTIC RESPONSE SHORTENED |
8 |
0.0002 |
| 930 |
PNEUMONIA ASPIRATION |
6 |
0.0002 |
| 931 |
GAIT INABILITY |
8 |
0.0002 |
| 932 |
PRODUCT QUALITY ISSUE |
32 |
0.0002 |
| 933 |
HAEMATOCHEZIA |
13 |
0.0002 |
| 934 |
PLATELET COUNT DECREASED |
25 |
0.0002 |
| 935 |
RASH GENERALISED |
6 |
0.0002 |
| 936 |
HEART RATE DECREASED |
8 |
0.0002 |
| 937 |
HERPES ZOSTER |
13 |
0.0002 |
| 938 |
FEMUR FRACTURE |
7 |
0.0002 |
| 939 |
LIMB INJURY |
6 |
0.0002 |
| 940 |
PALLOR |
6 |
0.0002 |
| 941 |
CRYING |
8 |
0.0002 |
| 942 |
INJECTION SITE PAIN |
66 |
0.0002 |
| 943 |
HAEMOPTYSIS |
6 |
0.0002 |
| 944 |
SEPTIC SHOCK |
9 |
0.0002 |
| 945 |
DYSSTASIA |
6 |
0.0002 |
| 946 |
GASTRIC DISORDER |
7 |
0.0002 |
| 947 |
DISEASE PROGRESSION |
24 |
0.0002 |
| 948 |
ABNORMAL BEHAVIOUR |
8 |
0.0002 |
| 949 |
NEOPLASM PROGRESSION |
7 |
0.0002 |
| 950 |
HALLUCINATION |
15 |
0.0002 |
| 951 |
EPILEPSY |
6 |
0.0002 |
| 952 |
BONE DENSITY DECREASED |
6 |
0.0002 |
| 953 |
BLOOD BILIRUBIN INCREASED |
5 |
0.0002 |
| 954 |
DEEP VEIN THROMBOSIS |
12 |
0.0002 |
| 955 |
VAGINAL HAEMORRHAGE |
8 |
0.0002 |
| 956 |
PRODUCT STORAGE ERROR |
16 |
0.0002 |
| 957 |
DEVICE DELIVERY SYSTEM ISSUE |
5 |
0.0002 |
| 958 |
INFLUENZA LIKE ILLNESS |
15 |
0.0002 |
| 959 |
SEIZURE |
21 |
0.0002 |
| 960 |
LEUKOPENIA |
9 |
0.0002 |
| 961 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
8 |
0.0002 |
| 962 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
6 |
0.0002 |
| 963 |
ELECTROCARDIOGRAM QT PROLONGED |
6 |
0.0002 |
| 964 |
INFUSION RELATED REACTION |
11 |
0.0002 |
| 965 |
INTERSTITIAL LUNG DISEASE |
8 |
0.0002 |
| 966 |
DRUG DOSE OMISSION |
27 |
0.0002 |
| 967 |
HEPATIC FUNCTION ABNORMAL |
6 |
0.0002 |
| 968 |
DRUG WITHDRAWAL SYNDROME |
14 |
0.0002 |
| 969 |
PRODUCT DOSE OMISSION |
10 |
0.0002 |
| 970 |
INJECTION SITE HAEMORRHAGE |
12 |
0.0002 |
| 971 |
DRUG EXPOSURE DURING PREGNANCY |
5 |
0.0001 |
| 972 |
RENAL CANCER |
7 |
0.0001 |
| 973 |
DRUG INTOLERANCE |
14 |
0.0001 |
| 974 |
DELIRIUM |
5 |
0.0001 |
| 975 |
DEVICE USE ERROR |
5 |
0.0001 |
| 976 |
NEUTROPENIA |
19 |
0.0001 |
| 977 |
FOETAL EXPOSURE DURING PREGNANCY |
11 |
0.0001 |
| 978 |
DEATH |
115 |
0.0001 |
| 979 |
MATERNAL EXPOSURE DURING PREGNANCY |
11 |
0.0001 |
| 980 |
DEVICE ISSUE |
11 |
0.0001 |
| 981 |
MALIGNANT NEOPLASM PROGRESSION |
12 |
0.0001 |
| 982 |
RHEUMATOID ARTHRITIS |
13 |
0.0001 |
| 983 |
PROSTATE CANCER |
9 |
0.0001 |
| 984 |
DEVICE MALFUNCTION |
7 |
0.0001 |
| 985 |
ILL-DEFINED DISORDER |
6 |
0.0001 |
| 986 |
BREAST CANCER |
9 |
0.0001 |
| 987 |
ANAPHYLACTIC REACTION |
5 |
0.0001 |
| 988 |
FEBRILE NEUTROPENIA |
6 |
0.0001 |
| 989 |
INJECTION SITE REACTION |
6 |
0.0001 |
| 990 |
DRUG ABUSE |
6 |
0.0001 |
| 991 |
DRUG DOSE OMISSION BY DEVICE |
5 |
0.0001 |